The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

A phase II, open-label study of durvalumab in combination with stereotactic body radiotherapy in androgen-intact patients with oligometastatic prostate cancer.

Isobel  Porter

Travel, Accommodations, Expenses - Merck Serono

Thomas  Eade

No Relationships to Disclose

Andrew  Kneebone

No Relationships to Disclose

George  Hruby

No Relationships to Disclose

Sophie  Mascall

No Relationships to Disclose

Alexander P.  Davis

No Relationships to Disclose

Alexander David  Guminski

Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Pfizer; Prime Oncology; Regeneron; Sun Pharma

Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medivation/Astellas; Merck KGaA; Sun Pharma